Hikma Pharmaceuticals (HKMPF) Short Interest Ratio & Short Volume $25.02 0.00 (0.00%) As of 01/3/2025 Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartDividendHeadlinesShort Interest Hikma Pharmaceuticals Short Interest DataHikma Pharmaceuticals (HKMPF) has a short interest of 1.53 million shares. This marks a 0.61% increase in short interest from the previous month. The short interest ratio (days to cover) is 1,276.1, indicating that it would take 1,276.1 days of the average trading volume of 308 shares to cover all short positions.Current Short Interest1,531,300 sharesPrevious Short Interest1,522,000 sharesChange Vs. Previous Month+0.61%Dollar Volume Sold Short$38.08 millionShort Interest Ratio1,276.1 Days to CoverLast Record DateDecember 15, 2024Outstanding Shares220,230,000 sharesPercentage of Shares Shorted0.70%Today's Trading Volume50 sharesAverage Trading Volume308 sharesToday's Volume Vs. Average16% Short Selling Hikma Pharmaceuticals? Sign up to receive the latest short interest report for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHKMPF Short Interest Over TimeHKMPF Days to Cover Over TimeHKMPF Percentage of Float Shorted Over Time Hikma Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/15/20241,531,300 shares $38.08 million +0.6%N/A1276.1 $24.87 11/30/20241,522,000 shares $37.24 million -0.3%N/A15220 $24.47 11/15/20241,526,800 shares $34.44 million +1.1%N/A15268 $22.56 10/31/20241,509,700 shares $37.85 million -2.9%N/A0 $25.07 10/15/20241,554,200 shares $39.10 million +0.7%N/A15542 $25.16 9/30/20241,544,100 shares $39.68 million -0.3%N/A15441 $25.70 Get the Latest News and Ratings for HKMPF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 9/15/20241,547,900 shares $39.78 million +0.4%N/A15479 $25.70 8/31/20241,541,500 shares $40.02 million -2.1%N/A2202.1 $25.96 8/15/20241,574,300 shares $41.04 million -17.0%N/A1211 $26.07 7/31/20241,896,300 shares $45.51 million +0.2%N/A3792.6 $24.00 7/15/20241,892,500 shares $44.86 million +0.1%N/A6308.3 $23.70 6/30/20241,891,200 shares $47.75 million +1.0%N/A18912 $25.25 6/15/20241,872,400 shares $47.28 million +0.5%N/A3744.8 $25.25 5/31/20241,862,300 shares $45.63 million -0.1%N/A18623 $24.50 5/15/20241,863,300 shares $45.65 million +0.7%N/A6211 $24.50 4/30/20241,849,700 shares $41.30 million +6.2%N/A9248.5 $22.33 4/15/20241,741,900 shares $42.24 million 0.0%N/A5806.3 $24.25 3/31/20241,742,100 shares $40.71 million +0.2%N/A8710.5 $23.37 3/15/20241,739,000 shares $40.64 million 0.0%N/A8695 $23.37 2/29/20241,739,100 shares $46.09 million +0.1%N/A5797 $26.50 2/15/20241,737,700 shares $43.44 million -1.2%N/A2172.1 $25.00 1/15/20241,756,000 shares $43.30 million No ChangeN/A8780 $24.66 12/31/20231,756,000 shares $40.01 million -10.0%N/A2676.8 $22.79 12/15/20231,951,100 shares $43.02 million +0.1%N/A19511 $22.05 11/30/20231,948,900 shares $42.95 million +0.3%N/A721.8 $22.04 11/15/20231,944,100 shares $43.28 million +0.5%N/A4860.3 $22.26 10/31/20231,934,300 shares $45.24 million +4.5%N/A4835.8 $23.39 10/15/20231,850,400 shares $46.97 million +5.5%N/A9252 $25.38 9/30/20231,754,100 shares $47.36 million -1.1%N/A17541 $27.00 9/15/20231,774,300 shares $47.91 million -0.1%N/A17743 $27.00 8/31/20231,775,300 shares $47.93 million +0.1%N/A1894.6 $27.00 8/15/20231,774,500 shares $46.94 million +0.1%N/A4436.3 $26.45 7/31/20231,773,300 shares $46.90 million +13.1%N/A479.3 $26.45 7/15/20231,567,500 shares $36.24 million 0.0%N/A1045 $23.12 6/30/20231,567,700 shares $36.21 million -8.0%N/A7838.5 $23.10 6/15/20231,703,900 shares $40.89 million +0.4%N/A8519.5 $24.00 5/31/20231,697,100 shares $39.03 million -0.3%N/A5657 $23.00 5/15/20231,702,000 shares $38.96 million -0.7%N/A17020 $22.89 4/30/20231,714,200 shares $39.72 million +0.4%N/A2857 $23.17 4/15/20231,707,400 shares $35.24 million +11.9%N/A17074 $20.64 3/31/20231,526,500 shares $30.94 million -2.7%N/A1908.1 $20.27 3/15/20231,569,000 shares $32.38 million -0.2%N/A2241.4 $20.64 2/28/20231,571,400 shares $33.20 million +0.3%N/A3928.5 $21.13 2/15/20231,567,000 shares $32.67 million -0.9%N/A3134 $20.85 1/31/20231,580,400 shares $29.82 million +0.6%N/A0 $18.87 1/15/20231,571,500 shares $29.65 million -0.6%N/A0 $18.87 12/30/20221,581,500 shares $29.84 million +0.0%N/A3953.8 $18.87 12/15/20221,581,200 shares $29.84 million -0.1%N/A15812 $18.87 11/30/20221,582,800 shares $22.62 million -0.3%N/A3165.6 $14.29 11/15/20221,588,000 shares $22.69 million +0.3%N/A15880 $14.29 10/31/20221,582,900 shares $22.62 million +0.2%N/A3165.8 $14.29 10/15/20221,579,400 shares $22.55 million +0.4%N/A493.6 $14.28 9/30/20221,572,800 shares $21.64 million +0.2%N/A1966 $13.76 9/15/20221,569,100 shares $23.32 million +114.5%N/A412.9 $14.86 8/31/2022731,700 shares $10.87 million No ChangeN/A385.1 $14.86 8/15/2022731,700 shares $14.20 million +0.5%N/A7317 $19.41 7/31/2022727,800 shares $14.62 million +0.5%N/A7278 $20.09 7/15/2022724,400 shares $14.22 million +54.8%N/A2414.7 $19.63 6/30/2022468,100 shares $8.51 million +0.3%N/A173.4 $18.19 6/15/2022466,700 shares $9.72 million +16.2%N/A4667 $20.82 5/31/2022401,700 shares $8.36 million +3,454.9%N/A0 $20.82 5/15/202211,300 shares $235,266.00 -86.6%N/A4.7 $20.82 4/30/202284,600 shares $2.37 million -1.7%N/A282 $28.00 4/15/202286,100 shares $2.41 million -1.3%N/A861 $28.00 3/31/202287,200 shares $2.44 million +87.1%N/A79.3 $28.00 3/15/202246,600 shares $1.13 million +639.7%N/A66.6 $24.30 2/28/20226,300 shares $176,400.00 -19.2%N/A21 $28.00 2/15/20227,800 shares $210,600.00 -41.8%N/A78 $27.00 1/31/202213,400 shares $361,130.00 -1.5%N/A33.5 $26.95 1/15/202213,600 shares $384,200.00 -26.5%N/A34 $28.25 12/31/202118,500 shares $529,840.00 -66.5%N/A46.3 $28.64 12/15/202155,200 shares $1.60 million +1,477.1%N/A276 $28.92 11/30/20213,500 shares $112,000.00 +169.2%N/A35 $32.00 11/15/20211,300 shares $41,600.00 +44.4%N/A13 $32.00 10/29/2021900 shares $28,800.00 -35.7%N/A9 $32.00 10/15/20211,400 shares $44,800.00 +7.7%N/A14 $32.00 9/30/20211,300 shares $44,525.00 -23.5%N/A13 $34.25 9/15/20211,700 shares $58,310.00 -97.8%N/A17 $34.30 8/31/202177,600 shares $2.66 million -72.7%N/A388 $34.30 8/13/2021284,000 shares $9.94 million -13.2%N/A946.7 $35.00 7/30/2021327,200 shares $11.99 million -11.1%N/A218.1 $36.65 7/15/2021368,000 shares $12.69 million -31.2%N/A613.3 $34.49 6/30/2021534,900 shares $17.65 million +1.5%N/A2674.5 $33.00 6/15/2021526,900 shares $18.05 million +11.8%N/A50.7 $34.25 5/28/2021471,200 shares $16.44 million -11.3%N/A785.3 $34.90 5/14/2021530,900 shares $17.20 million +1.9%N/A1327.3 $32.39 4/30/2021520,800 shares $17.37 million +71.7%N/A1041.6 $33.35 4/15/2021303,400 shares $10.01 million -19.7%N/A505.7 $33.00 3/31/2021377,700 shares $11.65 million -26.6%N/A1259 $30.85 3/15/2021514,700 shares $16.32 million +3.1%N/A735.3 $31.70 2/26/2021499,200 shares $16.27 million -0.8%N/A1664 $32.60 2/12/2021503,000 shares $16.10 million +90.2%N/A628.8 $32.00 1/29/2021264,500 shares $9.06 million +3.1%N/A661.3 $34.25 1/15/2021248,500 shares $8.80 million +5.2%N/A1242.5 $35.40 12/31/2020248,500 shares $8.54 million No ChangeN/A2485 $34.38 12/15/2020248,500 shares $8.41 million +5.2%N/A1242.5 $33.85 11/30/2020236,300 shares $8.24 million -0.5%N/A94.5 $34.86 11/15/2020237,500 shares $8.13 million +1.8%N/A593.8 $34.23 10/30/2020233,400 shares $7.92 million -20.9%N/A1167 $33.93 10/15/2020295,100 shares $10.33 million -0.5%N/A491.8 $35.00 9/30/2020296,700 shares $9.71 million +0.7%N/A185.4 $32.73 9/15/2020294,700 shares $10.17 million -9.6%N/A50.8 $34.50 8/31/2020326,000 shares $10.17 million -41.6%N/A296.4 $31.19 8/14/2020558,500 shares $16.25 million +16.6%N/A797.9 $29.10 7/31/2020479,200 shares $13.23 million +2.6%N/A1597.3 $27.60 7/15/2020467,000 shares $12.38 million +5.7%N/A311.3 $26.50 6/30/2020441,900 shares $12.15 million -13.4%N/A192.1 $27.50 6/15/2020510,300 shares $14.29 million -4.6%N/A2551.5 $28.00 5/29/2020535,100 shares $17.12 million -4.7%N/A594.6 $32.00 5/15/2020561,500 shares $16.79 million -9.1%N/A467.9 $29.90 4/30/2020617,700 shares $18.53 million -2.5%N/A166.9 $30.00 4/15/2020633,700 shares $18.03 million +11.9%N/A81.2 $28.45 3/31/2020566,400 shares $16.09 million +4.6%N/A145.2 $28.40 3/13/2020541,300 shares $14.56 million -4.4%N/A902.2 $26.90 2/28/2020566,200 shares $13.82 million +5.8%N/A5662 $24.40 2/14/2020535,000 shares $13.11 million +12.9%N/A1783.3 $24.50 1/31/2020473,700 shares $11.56 million +4.3%N/A128 $24.40 1/15/2020454,400 shares $10.45 million +2.2%N/A4544 $23.00 HKMPF Short Interest - Frequently Asked Questions What is Hikma Pharmaceuticals' current short interest? Short interest is the volume of Hikma Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of December 15th, traders have sold 1,531,300 shares of HKMPF short. Learn More on Hikma Pharmaceuticals' current short interest. What is a good short interest ratio for Hikma Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HKMPF shares currently have a short interest ratio of 1,276.0. Learn More on Hikma Pharmaceuticals's short interest ratio. Is Hikma Pharmaceuticals' short interest increasing or decreasing? Hikma Pharmaceuticals saw a increase in short interest in December. As of December 15th, there was short interest totaling 1,531,300 shares, an increase of 0.6% from the previous total of 1,522,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Hikma Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "private households" compare to Hikma Pharmaceuticals: Epiroc AB (publ) (0.00%), Ajinomoto Co., Inc. (0.00%), CK Hutchison Holdings Limited (0.00%), Commerzbank AG (0.00%), SGS SA (0.00%), Associated British Foods plc (0.01%), H & M Hennes & Mauritz AB (publ) (0.00%), Central Japan Railway (0.01%), Sandoz Group AG (0.18%), China Minsheng Banking Corp., Ltd. (0.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.32 billion), Spotify Technology S.A. ($4.06 billion), Canadian Natural Resources Limited ($3.45 billion), Reddit, Inc. ($2.79 billion), International Paper ($2.70 billion), Cencora, Inc. ($2.27 billion), SoFi Technologies, Inc. ($2.21 billion), Lululemon Athletica Inc. ($2.13 billion), and Rivian Automotive, Inc. ($2.05 billion). View all of the most shorted stocks. What does it mean to sell short Hikma Pharmaceuticals stock? Short selling HKMPF is an investing strategy that aims to generate trading profit from Hikma Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Hikma Pharmaceuticals? A short squeeze for Hikma Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HKMPF, which in turn drives the price of the stock up even further. How often is Hikma Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HKMPF, twice per month. The most recent reporting period available is December, 15 2024. More Short Interest Resources from MarketBeat Related Companies EPOKY Short Squeeze AJINY Short Squeeze CKHUY Short Squeeze CRZBY Short Squeeze SGSOY Short Squeeze ASBFY Short Squeeze HNNMY Short Squeeze CJPRY Short Squeeze SDZNY Short Squeeze CMAKY Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:HKMPF) was last updated on 1/5/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. ...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hikma Pharmaceuticals PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Hikma Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HKMPF Stock Alerts